Alzheimer's disease and Medical Cannabis
What is
Alzheimer's disease
Alzheimer’s disease is a progressive neurological condition and the most common cause of dementia. It gradually affects memory, thinking, language, behaviour, and everyday independence as brain cells become damaged over time.
Treatment Options for
Alzheimer's disease
Treatment focuses on supporting cognition, daily functioning, and quality of life. This may include memory-supporting medicines, occupational therapy, structured routines, carer support, and practical planning for changing care needs.
Medical Cannabis and
Alzheimer's disease
Medical cannabis is sometimes discussed in relation to symptoms that can accompany dementia, such as agitation, sleep disruption, anxiety, or reduced appetite. Cannabinoids may influence neurological signalling and inflammatory pathways, although any use in this area requires careful clinical judgement and close supervision.
Research & Evidence
Research into cannabinoids and neurodegenerative disease is ongoing, with early interest in possible neuroprotective, anti-inflammatory, and symptom-management effects. At present, evidence remains limited and treatment decisions should be individualised, especially in older adults with complex medical needs.
Explore Your Treatment Options
If Alzheimer’s disease is affecting comfort, appetite, sleep, or distress levels, a specialist clinician may help review supportive treatment options in the context of the person’s overall health and care plan. Any discussion of cannabinoid treatment should take into account cognition, safety, medication interactions, and carer support.